Meet the editor

Dr. Mourad Aribi, PhD, Dr. Hab., HDR, is a professor of immunology at the University of Tlemcen (Algeria), and the founder and director of the Laboratory of Applied Molecular Biology and Immunology (W0414100). His creativity allowed him to construct for the first time Master's and PhD training programs in immunology at his university, welcoming students and young researchers from different regions and countries. His current

research focuses on the modulation of cell-mediated and inflammatory immune responses in autoimmune diseases, cancer diseases, and infectious diseases. Thanks to his interdisciplinary skills, he was able to develop numerous high-level bilateral and multilateral collaboration projects with large teams, in particular with partners from CNRS and INSERM (Montpellier, Marseille, Burgundy-Franche-Comté, France), Institute for Immunodeficiency (Freibourg, Germany), and, more recently, with partners from Harvard Medical School (Boston, USA). He is a regular reviewer for many international scientific journals and is also a member of the editorial board of Frontiers in Immunology (the official journal of the International Union of Immunological Societies).

Contents

**Section 1**

*by Mourad Aribi*

*by Mourad Aribi*

B-Cell Lymphomas

*by Željka Škunca*

**Section 3**

B Cell Lymphomagenesis

Diffuse Large B-Cell Lymphoma

Residual Disease in Acute Leukemia

*and Nikolay Nikolayevich Tupitsyn*

**Section 2**

Introductory Chapter: B-Cells

**Preface III**

B-Cells **1**

**Chapter 1 3**

**Chapter 2 23**

B-Cell Lymphomagenesis **45**

**Chapter 3 47**

**Chapter 4 75**

**Chapter 5 93**

Minimal Residual Disease and Acute Leukemia **105**

**Chapter 6 107** B-Cell Precursors: Immunophenotypic Features in the Detection of Minimal

*by Patrascu Ana Maria, Ionela Rotaru, Valeriu Surlin and Stefan Patrascu*

*by Olga Chernysheva, Lyudmila Yuryevna Grivtsova, Alexander Popa* 

*by Subramanian Kalaivani Selvi, B.H. Srinivas and Sadhanandham Shrinuvasan*

Immunogenetic Aspect of B-Cell Antigen Receptor Diversity Generation
